SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Longer term short term day trades.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Steve Felix11/13/2020 9:51:31 AM
   of 1932
 
Cassava Sciences Inc. said Friday it priced its previously announced underwritten public offering.

The clinical-stage biotechnology company is offering 9.4 million shares of common stock at $8 a share.
The company also has granted the underwriters a 30-day option to purchase up to an additional 1.4 million shares of stock.

Had another bid in for 200 @ $7.96, but currently trading at a 10% premium to the offer.

Only three million shares traded so maybe they are not in their yet.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext